DNABII targeting antibodies as vaccines against biofilm diseases
Open Access
- 30 July 2020
- journal article
- editorial
- Published by Elsevier BV in EBioMedicine
- Vol. 58, 102921
- https://doi.org/10.1016/j.ebiom.2020.102921
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
This publication has 9 references indexed in Scilit:
- Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infectionsEBioMedicine, 2020
- Biofilm dispersionNature Reviews Microbiology, 2020
- Redirecting the immune response towards immunoprotective domains of a DNABII protein resolves experimental otitis medianpj Vaccines, 2019
- Antibodies against the Majority Subunit (PilA) of the Type IV Pilus of Nontypeable Haemophilus influenzae Disperse Moraxella catarrhalis from a Dual-Species BiofilmmBio, 2018
- Options and Limitations in Clinical Investigation of Bacterial BiofilmsClinical Microbiology Reviews, 2018
- Biofilm-related diseaseExpert Review of Anti-infective Therapy, 2017
- Microbial Biofilms and Chronic WoundsMicroorganisms, 2017
- Evaluation of the kinetics and mechanism of action of anti‐integration host factor‐mediated disruption of bacterial biofilmsMolecular Microbiology, 2014
- Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteinsMucosal Immunology, 2011